3 completed, 2 unknown, 1 terminated. 6 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Unknown 2, Terminated 1 |
| Phase 1 | 2 | Terminated 1, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Hypertension, Renal: new trials by email Literature Review of Hypertension, Renal trials Research Report on Hypertension, Renal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension MLS-101 (Part I), Placebo (Part I), Placebo (Part II) - Hypertension, Renal | Phase 2 | Completed | Mineralys Therapeutics Inc. | 200 | 2021-07-01 | 2024-01-05 |
| Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress mycophenolate mofetil (MMF), Placebo - Psychological Stress, Hypertension, Renal | Phase 1 / Phase 2 | Unknown | Augusta University | 50 | 2014-04-22 | 2019-06-20 |
| Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery Bendavia, Placebo - Renal Artery Obstruction, Hypertension, Renovascular | Phase 1 / Phase 2 | Terminated | Stealth BioTherapeutics Inc. | 16 | 2012-12-01 | 2020-08-11 |
| Renal Stenting With Distal Atheroembolic Protection Percutaneous renal stenting intervention, Distal embolic protection - Renal Artery Obstruction, Renovascular Hypertension | Phase 2 / Phase 3 | Unknown | Universita di Verona | 150 | 2009-03-01 | 2010-01-25 |
| Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant Rituximab, Mycophenolate mofetil (MMF) - Kidney Failure, Chronic, Diabetic Nephropathies | Phase 2 | Completed | University of Washington | 14 | 2006-12-01 | 2010-04-06 |
| Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant. mycophenolate mofetil (CellCept) - Kidney Failure, Chronic, Diabetic Nephropathies | Phase 2 | Completed | University of Washington | 45 | 2006-04-01 | 2010-04-15 |
Diabetes Mellitus (2) · Diabetic Nephropathies (2) · Glomerulonephritis, IGA (2) · Hypertension (2) · Hypertension, Renovascular (2) · Kidney Diseases (2) · Kidney Failure, Chronic (2) · Renal Artery Obstruction (2) · Renal Insufficiency (1) · Reperfusion Injury (1) · Stress, Psychological (1)
Cardiovascular Diseases (6) · Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Male Urogenital Diseases (6) · Urogenital Diseases (6) · Urologic Diseases (6) · Vascular Diseases (6) · Hypertension (4) · Kidney Diseases (4) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Arterial Occlusive Diseases (2) · Autoimmune Diseases (2) · Chronic Disease (2) · Diabetes Complications (2)
Mycophenolic Acid (3) · Rituximab (1) · arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide (1)
University of Washington (2) · Augusta University (1) · Mineralys Therapeutics Inc. (1) · Stealth BioTherapeutics Inc. (1) · Universita di Verona (1)
United States (4) · Italy (1)
Connie L Davis, MD (2) · Giancarlo Mansueto, MD, professor (1) · Gregory A Harshfield, PhD (1) · Richard Straube, MD (1) · Stephen C Textor, MD (1)